Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The NECTAR-HF feasibility trial is designed to evaluate the application of right vagal nerve stimulation in heart failure patients with a New York Heart Association Class III, an ejection fraction equal to or less than 35 %, and a narrow QRS duration equal to or less than 130 ms.
Epistemonikos ID: 6ade0b37f97a4c939cb5fb227a5ea53dacbbb418
First added on: May 06, 2024